NS
Insider
Nikita Shah
Executive Vice PresidentNikita Shah (Executive Vice President) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $2.6M of AMRX (146,403 sh × $17.51, as filed), executed Aug 12.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.1M
shares × price, as filed
Last traded
Aug 12
Filed Aug 13
Median ADV $37.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
AMRX
Amneal Pharmaceuticals, Inc.
AMRX · 0 buys · 6 sells
6 filings
Recent filings
AMRXSALE
Amneal Pharmaceuticals, Inc.
View filing →
$2.6M146,403 sh × $17.51
Exec Aug 12
Filed Aug 13 · 4:22 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $1.6M
131,856 sh × $11.92
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $1.1M
114,492 sh × $9.66
Exec Aug 22 2025
Filed Aug 25 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $666K
71,694 sh × $9.29
Exec Aug 14 2025
Filed Aug 15 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $452K
50,000 sh × $9.04
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $372K
49,140 sh × $7.58
Exec May 16 2025
Filed May 19 2025 · 5:30 PM ET